Standard BioTools Inc (LAB) is looking forward to a strong quarter

With 1.08 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.69 million shares. The 52-week range on LAB shows that it touched its highest point at $3.04 and its lowest point at $1.17 during that stretch. It currently has a 1-year price target of $3.08. Beta for the stock currently stands at 1.57.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LAB was down-trending over the past week, with a drop of -2.26%, but this was down by -28.96% over a month. Three-month performance dropped to -13.33% while six-month performance fell -30.11%. The stock lost -48.00% in the past year, while it has lost -25.71% so far this year. A look at the trailing 12-month EPS for LAB yields -0.71 with Next year EPS estimates of -0.20. For the next quarter, that number is -0.06. This implies an EPS growth rate of 62.06% for this year and 43.93% for next year. EPS is expected to grow by 56.66% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 8.72%.

Float and Shares Shorts:

At present, 372.26 million LAB shares are outstanding with a float of 360.41 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for LAB since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.34635 being high and -$0.36942 being low. For LAB, this leads to a yearly average estimate of -$0.35667. Based on analyst estimates, the high estimate for the next quarter is -$0.04 and the low estimate is -$0.04. The average estimate for the next quarter is thus -$0.04.